A Quick Knockin mouse defines an animal model in which a transgene is inserted in a permissive locus, also known as neutral locus or safe harbor, such as example Rosa26 and Hprt. The transgene can be constitutively or inducibly overexpressed.

Targeting those loci enable a full control of the copy number and avoid transgene silencing or deregulation of neighboring genes.

Applications

For academic research:

  • Gene function studies by overexpression if Knockout has no or little phenotype
  • Rescue experiment to validate specificity of the Knockout phenotype
  • Protein structure and function studies
  • Expression pattern analysis
  • Expression of specific isoform to decipher its particular function
  • Express human gene that has no mouse orthologue
  • Model of dominant negative or gain-of-function mutation of human disease

For bio-pharmaceutical research & development:

  • Validate drug candidate by expression of mutant form of receptor mimicking its role
  • Validate mutation in target as disease-causing agent
  • Test protective effect on controlled gene expression on disease onset or progression
  • Identification biomarkers in human disease model
  • Get mouse model that cross-reacts with human-specific therapeutic antibody (or similar)

Strengths of Quick Knockin mouse models

  • Very robust approach due to the wide usage of both, Rosa26 and Hprt, by scientific community
  • Fast development due to ready-to-use vectors
  • Several genetic backgrounds are available (C57Bl/6, BALB/c…)
  • Variety of genetic designs to fit a broad range of applications

Limitations of Quick Knockin mouse models

  • No physiological regulation of the transgene expression
    →  Limitation can be bypassed by using conventional Knockin approach
  • In most cases only one isoform can be expressed
  • Mutated mouse gene is expressed in presence of the wildtype gene

Case Study

Model recapitulating key features of human tauopathies.

Bondulich MK, et al. Tauopathy induced by low level expression of a human brain-derived tau fragment in mice is rescued by phenylbutyrate. Brain. 2016.

Tauopathies are characterized by progressive cognitive and/or motor dysfunction, together with highly phosphorylated aggregates of the microtubule-associated protein tau in brain and peripheral nerve.

Most existing mouse models of tauopathy overexpress mutant tau at levels that do not occur in human neurodegenerative disease.

Model: New highly disease-relevant mouse model of tauopathy expressing Hprt locus-targeted Tau35, highly phosphorylated C-terminal human tau fragment.

Aim: Evaluate a new model of tauopathy for developing novel treatments for human tauopathies.

Results: Tau35 mice represent a pathophysiologically relevant mouse model in which to test new, potentially disease-modifying therapies.

Figure 1. Tau expression in Tau35 mouse brains

Excessive accumulation of cGMP and subsequent rod photoreceptor death, followed by a mutation-independent, secondary death of cone photoreceptors.

Figure 1a - Tau35 mice

A) RT-PCR confirms Tau35 expression.

B) Sagittal sections show widespread hemagglutinin labeling in Tau35 mouse brain (upper panels, scale bar = 2 mm). Higher magnifications of the hippocampal CA1 region show strongly hemagglutinin-positive pyramidal neurons in Tau35 mice (lower panels, scale bar = 200 mm). Western blots of frontal region and hippocampus/associated cortex (HC) show hemagglutinin protein expression only in Tau35 mice.

Figure 1b - Tau35 mice


Figure 2. Progressive neuromuscular impairment

Figure 2a-d - Tau35 mice

A) Limb clasping is apparent in Tau35 mice from 2 months of age (image shows 8 months), with all Tau35 animals affected by 18 months. Clasping is not observed in wildtype (wt) mice at any age examined.

B) Spine curvature is apparent in Tau35, but not wildtype mice, at 14 months of age. A progressive reduction in the kyphotic index in Tau35 mice after 4 months of age indicates increasing spine curvature.

C) Visible platform (VP) training in the Morris water maze was followed by 4 days of hidden platform training. At 10 months of age, Tau35 mice exhibit longer escape latency on the fourth day of testing compared to wildtype mice.

D) The grip strength of Tau35 mice declines steadily with age.

Figure 3. Phenylbutyrate rescues disease-related changes in Tau35 mice.

Figure 3ab - Tau35 mice

A) Morris water maze (10 months) testing of 4-phenylbutyrate (PBA, dotted lines) and vehicle-treated (solid lines) Tau35 (circles) and wildtype (wt, squares) mice. PBA-treated Tau35 mice show improved learning after 3 days, resulting in decreased escape latency.

B) Grip strength of Tau35 (10 months) is restored by PBA treatment.

Related ressources et publication
No results
No results
No results
No items found.
No results
No results
No results
No results

Discover related products to

Quick KI mouse

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Mouse
Knockin
Reporter
Customized

Reporter KI mouse

Use a reporter mouse Knockin for in vivo monitoring of transcriptional promoter activity, protein localization, cell trafficking, etc.

Mouse
Knockin
Point mutation
Customized

Point mutation KI mouse

Use a point mutation mouse Knockin to circumvent complex phenotypes arising from complete Knockouts (e.g., signaling pathway problems, cross-reactivity).

Mouse
Knockin
Customized

Humanized KI mouse

Use humanized mice as in vivo tools for mimicking human pathological conditions and diseases, and for conducting preclinical research.

Mouse
Knockout
Point mutation
Customized

Protein function KO mouse

A protein function Knockout mouse defines a model in which one or more nucleotides are mutated in a way that the protein loses its function.

Mouse
Knockout
Constitutive
Customized

Constitutive KO mouse

A constitutive, conventional, or whole-body Knockout mouse is a fast and cost-effective solution for in vivo preliminary studies of target gene functions.

Mouse
Knockout
Conditional
Time-dependent
Customized

Time-dependent KO mouse

Use an inducible conditional Knockout mouse to age-dependently inactivate your gene, and to enable studies at defined development stages or on age-related diseases.

Mouse
Knockout
Conditional
Tissue-specific
Customized

Tissue-specific KO mouse

Use tissue- or cell-specific conditional Knockout mouse models to bypass embryonic lethality, compensatory mechanisms, complex phenotypes, etc.

Discover our off-the-shelf models.

Learn more

Quick Knockin mouse models (Neutral locus targeting: Rosa26, Hprt)

Get in touch about

Let us know how we can help

In order to provide you the content requested, we need to store and process your personal data. If you consent to us storing your personal data for this purpose, please tick the checkbox below.

From time to time, we would like to contact you about our products and services, as well as other content that may be of interest to you. If you consent to us contacting you for this purpose, please tick below.

You can unsubscribe from these communications at any time. For more information on how to unsubscribe, our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Policy.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.